Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome de Xia-Gibbs é um distúrbio genético causado por uma mutação heterozigótica no gene AHDC1 no cromossomo 1p36.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
4
pacientes catalogados
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, RS, ES, RJ +5CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
33 sintomas
😀
Face
23 sintomas
🦴
Ossos e articulações
20 sintomas
👁️
Olhos
10 sintomas
👂
Ouvidos
8 sintomas
🫁
Pulmão
6 sintomas

+ 77 sintomas em outras categorias

Características mais comuns

100%prev.
Crise tônico-clônica bilateral com início focal
Obrigatório (100%)
100%prev.
Atrofia cortical frontal
Obrigatório (100%)
100%prev.
Sinostose bicoronal
Obrigatório (100%)
100%prev.
Trismo
Obrigatório (100%)
100%prev.
Capacidade de higiene pessoal prejudicada
Obrigatório (100%)
100%prev.
Atrofia muscular espinhal
Frequência: 2/2
199sintomas
Muito frequente (63)
Frequente (73)
Ocasional (59)
Muito raro (3)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 199 características clínicas mais associadas, ordenadas por frequência.

Crise tônico-clônica bilateral com início focalBilateral tonic-clonic seizure with focal onset
Obrigatório (100%)100%
Atrofia cortical frontalFrontal cortical atrophy
Obrigatório (100%)100%
Sinostose bicoronalBicoronal synostosis
Obrigatório (100%)100%
TrismoTrismus
Obrigatório (100%)100%
Capacidade de higiene pessoal prejudicadaImpaired toileting ability
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202245 papers
Linha do tempo
2026Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

AHDC1Transcription factor GibbinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor required for the proper patterning of the epidermis, which plays a key role in early epithelial morphogenesis (PubMed:35585237). Directly binds promoter and enhancer regions and acts by maintaining local enhancer-promoter chromatin architecture (PubMed:35585237). Interacts with many sequence-specific zinc-finger transcription factors and methyl-CpG-binding proteins to regulate the expression of mesoderm genes that wire surface ectoderm stratification (PubMed:35585237)

LOCALIZAÇÃO

NucleusChromosome

MECANISMO DE DOENÇA

Xia-Gibbs syndrome

An autosomal dominant disorder characterized by intellectual disability, mild dysmorphism, hypotonia, delayed psychomotor development with absent or poor expressive language, hypoplasia of the corpus callosum, simplified gyral pattern, and delayed myelination.

OUTRAS DOENÇAS (1)
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome
HGNC:25230UniProt:Q5TGY3

Variantes genéticas (ClinVar)

311 variantes patogênicas registradas no ClinVar.

🧬 AHDC1: NM_001371928.1(AHDC1):c.1009del (p.Leu337fs) ()
🧬 AHDC1: NM_001371928.1(AHDC1):c.1942C>T (p.Gln648Ter) ()
🧬 AHDC1: NM_001371928.1(AHDC1):c.2667_2685del (p.Ser890fs) ()
🧬 AHDC1: NM_001371928.1(AHDC1):c.4741C>T (p.Pro1581Ser) ()
🧬 AHDC1: NM_001371928.1(AHDC1):c.1423G>C (p.Val475Leu) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 236 variantes classificadas pelo ClinVar.

130
106
Patogênica (55.1%)
VUS (44.9%)
VARIANTES MAIS SIGNIFICATIVAS
AHDC1: NM_001371928.1(AHDC1):c.1009del (p.Leu337fs) [Likely pathogenic]
AHDC1: NM_001371928.1(AHDC1):c.1942C>T (p.Gln648Ter) [Pathogenic]
AHDC1: NM_001371928.1(AHDC1):c.2667_2685del (p.Ser890fs) [Pathogenic]
AHDC1: NM_001371928.1(AHDC1):c.4012C>T (p.Arg1338Ter) [Pathogenic]
AHDC1: NM_001371928.1(AHDC1):c.3069_3084del (p.Pro1024fs) [Likely pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada

Centros para Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open2026 Feb 27

Down syndrome (DS) is a major cause of genetically defined intellectual disability, characterised by low IQ and cognitive deficits. Among the neurobiological causes of these deficits, disruptions in gamma-aminobutyric acid (GABA)ergic signalling in the hippocampus and an excitation/inhibition imbalance are thought to impair learning and memory. Evidence suggests that GABAA receptor-mediated signalling in DS is significantly depolarising and potentially excitatory rather than predominantly hyperpolarising and inhibitory, and is accompanied by increased hippocampal expression of the cation-chloride cotransporter NKCC1. The treatment with the NKCC1 inhibitor bumetanide restored GABAergic signals, synaptic plasticity, hippocampus-dependent memory and sleep quality in adult DS mice. We hypothesise that the use of bumetanide, by re-establishing GABAergic signals, may improve memory, learning and psychological characteristics in children and adolescents with DS. The present study is a randomised, double-blind, placebo-controlled trial to evaluate the efficacy of a 3-month treatment with the drug bumetanide (0.02 mg/kg two times per day or placebo) on memory and psychological functioning in children and adolescents with DS. We also aim to identify possible predictors and biological and genetic markers related to treatment.The target recruitment is 64 children and adolescents with DS (aged 10-17 years). Seven visits are scheduled for each participant, during which outcome and safety measures are assessed through various clinical and instrumental investigations.Outcome measures include neuropsychological and psychological assessments, as well as biomarkers. Neuropsychological measures consist of tests evaluating cognitive level, memory and executive functions. Psychological measures include parent-reported questionnaires on psychopathological and behavioural symptoms, quality of life, sleep and adaptive functioning. Biomarkers encompass electroencephalogram (EEG) and genomic, transcriptomic, proteomic and metabolomic evaluations from blood and urine samples.Safety measures include physical, nephrological, cardiological and audiometric evaluations, as well as blood and urine analysis, EEG, ECG and a pregnancy test (if applicable). Neuropsychological, psychological, biomarker and safety measures are collected at baseline (visit 1 (V1)), at the end of treatment (V6) and during follow-up (V7), which is scheduled for 2 months after the end of treatment. Interim psychological and safety assessments are conducted at 1 week (V2), 2 weeks (V3), 1 month (V4) and 2 months (V5) after the start of treatment. We expect bumetanide treatment to improve visual long-term memory skills (primary outcome). Additionally, we expect improvements in total scores and subdomain scores across other visual, verbal and spatial long-term memory tasks, as well as executive functions, psychopathological measures, adaptive functioning, sleep quality and quality of life scores (secondary outcomes). Furthermore, we expect potential differences in genomic, transcriptomic, proteomic and metabolomic profiles between patients who respond to therapy and those who do not. Ethical approval for this study was granted by the Bambino Gesù Children's Hospital Ethics Committee (process number 1042_OPBG_2016) and the Italian Medicines Agency. Substantial Amendment No 5 (ES5) was approved on 20 September 2023 by the Italian National Paediatric Ethics Committee and involved a revision and integration of the study protocol, now updated to version 8.1, in line with the recommendations of the Data Safety Monitoring Board.This study is being conducted in accordance with the Declaration of Helsinki. The present study protocol adheres to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines and was prepared using the SPIRIT 2025 Checklist. In accordance with Good Clinical Practice, written informed consent is obtained from all participants' parents or caregivers, and assent is obtained from participants when possible. The main features of the study will be presented at both international and national conferences, during scientific meetings, in presentations to families and on social media using documentation approved by competent authorities. The study was prospectively registered in the EudraCT portal on 16 August 2016, prior to the enrolment of the first participant on 11 January 2023 (https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005780-16/IT). In accordance with Regulation (EU) 536/2014 for pharmacological interventional trials, the study was subsequently transitioned to the Clinical Trials Information System (EU CT No 2024-519342-71-00), with the initial record entered on 23 December 2024, and the transition authorised on 3 February 2025 (https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-519342-71-00). EudraCT 2015-005780-16.

#2

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences2026 Feb 11

We report a thirty-six-year-old woman with intellectual disability who was referred for evaluation of suspected obstructive sleep apnea. The initial clinical impression suggested a syndromic case, so comprehensive genetic testing was undertaken. Overnight polysomnography revealed a severe rapid eye movement-predominant obstructive sleep apnea syndrome with an apnea-hypopnea index of 31.9 events per hour, rapid eye movement apnea-hypopnea index of 113.8 events per hour, and lowest oxygen saturation of 66%. Treatment with continuous positive airway pressure improved respiratory and sleep quality indices and was well tolerated. Whole-exome sequencing identified a de novo splice site variant in the pleckstrin homology domain interacting protein gene (c.41-1G > A), confirming a molecular diagnosis of Chung-Jansen Syndrome. Chung-Jansen syndrome is a rare neurodevelopmental disorder caused by heterozygous pathogenic variants in the pleckstrin homology domain interacting protein gene, marked by developmental delay, intellectual disability, behavioral abnormalities, dysmorphism, and progressive obesity. PHIP influences central and peripheral pathways controlling satiety, pancreatic function, and body weight. Despite frequent reports of sleep problems, systematic evaluation of sleep-disordered breathing has been limited. This adult case provides the first polysomnographic confirmation in the syndrome, supporting proactive screening for obstructive sleep apnea-especially in those with obesity. Integrating genetic assessment into sleep care can reduce diagnostic delays and better guide therapy and prognosis. AFF4-related CHOPS syndrome is characterized by coarse facial features / cognitive impairment, heart defects, obesity, pulmonary involvement, and short stature / skeletal abnormalities. All individuals reported to date have mild-to-moderate developmental delay and intellectual disability without regression. Neurobehavioral features include disruptive and self-absorbed behaviors, communication disturbance, and food-seeking behaviors leading to obesity. Characteristic facial features include synophrys, highly arched eyebrows, long eyelashes, proptosis, and anteverted nares. Coarse facies and round face with full cheeks become more noticeable with age. Other common features include growth deficiency, respiratory issues, congenital heart defects, small hands, brachydactyly, ocular abnormalities, genitourinary abnormalities, and gastrointestinal manifestations. The diagnosis of AFF4-related CHOPS syndrome is established in a proband with suggestive clinical findings and a heterozygous pathogenic variant in AFF4 identified by molecular genetic testing. To date, all CHOPS-related pathogenic variants are located in the AFF4 ALF homology domain. Treatment of manifestations: Developmental and educational support; feeding therapy; gastrostomy tube placement as needed; nutritional management for obesity; standard treatments for chronic lung disease and sleep apnea; standard vaccinations; tracheostomy as needed for laryngomalacia; standard treatment for congenital heart defects and vertebral anomalies; treatment of refractive errors and strabismus per ophthalmologist; treatment of cataract per ophthalmic subspecialist; hearing aids as needed for hearing loss; standard treatment of genitourinary anomalies and bowel dysfunction; transitional care plan by age ten years; social work and family support. Surveillance: Assess developmental progress, educational needs, behavior issues, growth, evidence of aspiration or respiratory insufficiency, musculoskeletal manifestations, nutritional status, safety of oral intake, gastrointestinal manifestations, and family needs at each visit. Assess for myopia and strabismus per ophthalmologist and at least annually; annual audiology evaluation. AFF4-related CHOPS syndrome is an autosomal dominant disorder. All probands reported to date with AFF4-related CHOPS syndrome whose parents have undergone molecular genetic testing have the disorder as the result of a de novo pathogenic variant. Risk to the parents of the proband of having another affected pregnancy is presumed to be low for the parents of the proband as the proband most likely has a de novo AFF4 pathogenic variant. There is, however, a recurrence risk (~1%) to sibs based on the possibility of parental gonadal mosaicism. Given this risk, prenatal and preimplantation genetic testing may be considered.

#3

Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.

Clinical genetics2026 Apr

O'Donnell-Luria-Rodan syndrome (ODLURO) is a rare disorder caused by a pathogenic variant in KMT2E and associated with intellectual disability. To date, the neurobehavioral phenotype of this disorder remains elusive. Here, we aimed to characterize the cognitive and behavioral profiles associated with ODLURO and compare the trends with those of other disorders associated with epigenetic regulation of gene expression at H3K4, Wiedemann-Steiner syndrome (WDSTS) and Kabuki syndrome type 1 (KABUK1). Findings show prominent behavioral features in ODLURO include problems with anxiety (33%), attention (67%), and executive function (50%) (working memory, cognitive inflexibility), with similar severity ratings as WDSTS and KABUK1. Two-thirds of participants were rated in the moderate-to-severe range in overall autism-like behaviors on the SRS-2; however, study findings highlighted a pattern of most day-to-day difficulties in Restricted/Repetitive Behaviors paired with relatively fewer challenges in Social Motivation, comparable to trends reported in WDSTS. Sleep disturbances are common in ODLURO (85%) and associated with behavior regulation difficulties, highlighting the importance of early screening/intervention. In brief, ODLURO shares similarities in neurobehavioral functioning with other disorders of H3K4 modulation of gene expression, warranting further systematic research with cross-syndrome comparisons to elucidate the relationship between epigenetic regulation and pathogenesis of neurodevelopmental disorders.

#4

Etiological Diagnosis and Disease Course of Birk-Barel Syndrome in an Adult Woman with a KCNK9 Variant.

International medical case reports journal2026

Birk-Barel syndrome (BIBARS), also known as KCNK9 imprinting syndrome, is an extremely rare genetic condition caused by pathogenic variants in the KCNK9 gene located on the long arm of chromosome 8 (8q24). This gene is paternally imprinted and therefore only expressed from the maternal allele. KCNK9 encodes for a member of the two-pore domain potassium channel (K2P) subfamily. BIBARS syndrome is characterized by congenital hypotonia and weakness of proximal muscles, intellectual disability, behavioural problems, dysmorphic features, feeding problems and epilepsy. The syndrome is implied in neurodevelopment, plays a role in various regulatory systems (eg, blood pressure maintenance, respiratory function, sleep, and cognitive function), and is associated with absence epilepsy. An institutionalized adult female patient with intellectual disability and challenging behaviours was presented whose history was carefully described and in whom extensive somatic, neurological, psychiatric and psychological investigation was performed, in addition to whole exome sequencing. Intellectual disability, developmental delay with severe psychotrauma from early age on, as well as severe aggressive and self-injurious behaviours were established. Whole exome sequencing finally disclosed a pathogenic variant in the KCNK9 gene and an absence epilepsy in association with BIBARS was suspected. After treatment with valproic acid epileptic phenomena no longer occurred and behaviour and emotion regulation improved significantly. A pathogenic heterozygous missense variant in the KCNK9 gene corresponding with a diagnosis of Birk-Barel syndrome was considered to be largely responsible for the severely disinhibited behaviours and causative for the absence epilepsy. For adequate diagnosis and treatment of neurodevelopmental disorders, this case clearly demonstrates the importance of adherence to clinical standards, in particular periodically renewed genetic analysis by means of WES/WGS.

#5

Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association2026 Feb

Adults with Down syndrome (DS) are at high risk for Alzheimer's disease (AD), the leading cause of death in this population. Survival in DS after AD diagnosis appears shorter than in sporadic AD; however, the factors influencing survival remain poorly understood. We analyzed 157 adults with DS from Spain and Ireland who died of AD between 2012 and 2024. Clinical, genetic, and care predictors were examined using Kaplan-Meier curves and Cox regression. Mean survival after AD diagnosis was 4.8 years (SD 3.5). Those in specialist intellectual disability dementia care had a longer survival time (mean 9.5 years) than other settings (mean 3.4 to 4.1 years; p < 0.001). Late-onset myoclonic epilepsy in DS (LOMEDS) was linked to a threefold higher risk of death after onset (p < 0.001). Specialist care settings and LOMEDS timing significantly shape survival in DS-associated AD, highlighting the importance of tailored services and proactive epilepsy treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Etiological Diagnosis and Disease Course of Birk-Barel Syndrome in an Adult Woman with a KCNK9 Variant.

International medical case reports journal
2026

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.

BMJ open
2026

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences
2026

Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2026

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes.

The Journal of clinical psychiatry
2025

Sexual Health and Transition Needs in an Adolescent Girl With Attention-deficit Hyperactivity Disorder and Smith-magenis Syndrome.

Journal of developmental and behavioral pediatrics : JDBP
2026

Respiratory Involvement in HIST1H1E-Related Rahman Syndrome: A Case of Severe Mixed Apnea.

American journal of medical genetics. Part A
2025

Effects of Metformin on children with Fragile X Syndrome: a randomized, double-blind, placebo-controlled trial.

Molecular autism
2026

Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.

Clinical genetics
2025

Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations.

Human molecular genetics
2026

The De Novo p.(Ser802Phe) Variant Causes Helsmoortel-Van der Aa/ ADNP Syndrome in a 24-Year-Old Woman and Is Predicted to Perturb ADNP-DNA Affinity.

American journal of medical genetics. Part A
2025

Specialists' perceptions of clinical instruments, practices, and staging of DS-AD: Results from an international survey.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

Scheduled feeding improves behavioral outcomes and reduces inflammation in a mouse model of fragile X syndrome.

eLife
2026

The Occurrence of Obstructive Sleep Apnea and Its Association With Alzheimer Dementia in Medicaid-Enrolled Adults With Down Syndrome, 2011-2019.

American journal of medical genetics. Part A
2025

Parental Stress and Family Quality of Life in Families of Individuals Living With Angelman Syndrome.

Journal of intellectual disability research : JIDR
2025

Characterizing healthcare resource utilization in two rare diseases (Kleefstra syndrome and SLC6A1 epileptic encephalopathy) using multimodal real-world data.

Orphanet journal of rare diseases
2025

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

Separation of telomere protection from length regulation by two different point mutations at amino acid 492 of RTEL1.

Nucleic acids research
2025

Fragile X syndrome: genetic and clinical profile in the Hong Kong Chinese population.

Hong Kong medical journal = Xianggang yi xue za zhi
2025

Characterisation of Challenging Behaviours and Associated Genetic and Neurological Features in Cardiofaciocutaneous Syndrome.

Journal of intellectual disability research : JIDR
2025

Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption.

Nature genetics
2025

Cell-type specific global reprogramming of the transcriptome and epigenome in induced neurons with the 16p11.2 neuropsychiatric CNVs.

European journal of human genetics : EJHG
2025

Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum.

Brain : a journal of neurology
2025

Neonatal obstructive sleep apneas in a mouse model of Down syndrome.

Journal of neurophysiology
2025

Psychotropic Medication Use in 48,XXYY Syndrome.

American journal of medical genetics. Part A
2025

Respiratory and airway disorders in children with Down Syndrome: a review of the clinical challenges and management.

Frontiers in pediatrics
2025

Christianson Syndrome Family Experiences: Results From Caregiver Interviews.

Journal of child neurology
2025

Molecular aspects of Angelman Syndrome: Defining the new path forward.

Biomolecules &amp; biomedicine
2025

Clinical profiling and medical management of Israeli individuals with Phelan McDermid syndrome.

Orphanet journal of rare diseases
2025

Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome.

Annals of neurology
2025

Circadian rhythm defects in Prader-Willi syndrome neurons.

HGG advances
2025

Multivariate deep phenotyping reveals behavioral correlates of non-restorative sleep in 22q11.2 deletion syndrome.

Psychiatry research
2025

Respiratory support in patients with Down syndrome: a systematic review.

European respiratory review : an official journal of the European Respiratory Society
2025

PAK3 pathogenic variant associated with sleep-related hypermotor epilepsy in a family with parental mosaicism.

Epilepsia open
2024

FMR1 Disorders: Basics of Biology and Therapeutics in Development.

Cells
2025

Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research Society.

Neuromolecular medicine
2025

RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report.

Neurology
2024

Sleep correlates of behavior functioning in Cornelia de Lange syndrome.

American journal of medical genetics. Part A
2024

Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome.

Journal of neurodevelopmental disorders
2024

The overlapping of phenotypes in Wiedemann-Steiner, Kleefstra and Coffin-Siris syndromes: a study of eleven patients.

Italian journal of pediatrics
2024

Association between sleep disturbances and challenging behavior in children and adolescents with Angelman syndrome.

Sleep medicine
2024

A Genotype/Phenotype Study of KDM5B-Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants.

Genes
2024

Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease.

International journal of molecular sciences
2024

Characterising repetitive behaviours in children and adolescents with Down syndrome.

Journal of intellectual disability research : JIDR
2024

Circadian Rhythm and Sleep Analyses in a Fruit Fly Model of Fragile X Syndrome Using a Video-Based Automated Behavioral Research System.

International journal of molecular sciences
2024

Clinical and functional studies of MTOR variants in Smith-Kingsmore syndrome reveal deficits of circadian rhythm and sleep-wake behavior.

HGG advances
2024

An investigation of sleep problems, gastrointestinal symptoms, comorbid psychopathology and challenging behavior in children and adolescents with Down Syndrome.

Research in developmental disabilities
2024

Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.

Journal of Alzheimer's disease : JAD
2024

MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature.

American journal of human genetics
2024

Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016-2023).

American journal of medical genetics. Part A
2024

Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome.

American journal of medical genetics. Part A
2023

A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation.

Neurocase
2024

Dental findings and intravenous sedation in a patient with Potocki-Lupski syndrome: A case report.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2024

DHCR7 links cholesterol synthesis with neuronal development and axonal integrity.

Biochemical and biophysical research communications
2024

The First Korean Case with Cardiac, Facial, and Digital Anomalies with Developmental Delay Caused by De Novo TRAF7 p.Arg655Gln Variant.

International journal of molecular sciences
2024

A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.

Epilepsy &amp; behavior : E&amp;B
2024

Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2024

Midline non-ictal rhythmic waveforms as possible electroencephalographic biomarkers of Smith-Klingsmore syndrome in children.

Clinical neurophysiology practice
2024

Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children.

Orphanet journal of rare diseases
2024

State-of-the-art therapies for fragile X syndrome.

Developmental medicine and child neurology
2024

Low-grade parental gonosomal mosaicism in CHD2 siblings with Smith-Magenis-like syndrome.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches.

Epilepsy research
2024

Clinical phenotype of FOXP1 syndrome: parent-reported medical signs and symptoms in 40 individuals.

Journal of medical genetics
2024

Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep.

Molecular genetics &amp; genomic medicine
2023

Rett and Rett-related disorders: Common mechanisms for shared symptoms?

Experimental biology and medicine (Maywood, N.J.)
2023

Health supervision for children and adolescents with 16p11.2 deletion syndrome.

Cold Spring Harbor molecular case studies
2023

Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management.

Ewha medical journal
2023

Quality of life in Down syndrome in Brazil: a cross-sectional study.

Arquivos de neuro-psiquiatria
2024

Child characteristics associated with child quality of life and parenting stress in Angelman syndrome.

Journal of intellectual disability research : JIDR
2024

Clinical phenotypes of individuals with Chung-Jansen syndrome across age groups.

American journal of medical genetics. Part A
2023

Electroclinical Features of Epilepsy in Kleefstra Syndrome.

Neuropediatrics
2023

An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.

Seizure
2023

Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant.

Genes
2023

Current and emerging treatment options for Angelman syndrome.

Expert review of neurotherapeutics
2024

Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2023

Nasal polyposis in pediatric patients with Cornelia de Lange syndrome: endoscopic diagnosis, treatment and follow up in two case reports.

Italian journal of pediatrics
2023

Hyperphagia and Down Syndrome.

Journal of developmental and behavioral pediatrics : JDBP
2023

Multivariate patterns of disrupted sleep longitudinally predict affective vulnerability to psychosis in 22q11.2 Deletion Syndrome.

Psychiatry research
2023

Sleep disturbances in Phelan-McDermid syndrome: Clinical and metabolic profiling of 56 individuals.

Clinical genetics
2023

Generation and mutational analysis of a transgenic murine model of the human MAF mutation.

American journal of medical genetics. Part A
2023

POU3F3-related disorder: Defining the phenotype and expanding the molecular spectrum.

Clinical genetics
2023

Parental perspectives on Phelan-McDermid syndrome: Results of a worldwide survey.

European journal of medical genetics
2023

Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health records.

The Lancet. Public health
2023

A Novel Variant in VPS13B Underlying Cohen Syndrome.

BioMed research international
2023

The epileptology of Wiedemann-Steiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

Consensus recommendations on sleeping problems in Phelan-McDermid syndrome.

European journal of medical genetics
2023

TELO2-related syndrome (You-Hoover-Fong syndrome): Description of 14 new affected individuals and review of the literature.

American journal of medical genetics. Part A
2023

Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders.

Genes
2022

Myoclonic-Atonic Epilepsy Caused by a Novel de Novo Heterozygous Missense Variant in the SLC6A1 Gene: Brief Discussion of the Literature and Detailed Case Description of a Severely Intellectually Disabled Adult Male Patient.

International medical case reports journal
2023

Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature.

European journal of human genetics : EJHG
2024

Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.

Journal of autism and developmental disorders
2022

Neurocognitive evaluation of children with down syndrome and obstructive sleep apnea syndrome.

Sleep medicine
2022

STAG2 microduplication in a patient with eyelid myoclonia and absences and a review of EMA-related reported genes.

European journal of medical genetics
2022

The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.

Translational psychiatry
2022

The Impact of the COVID-19 Pandemic on School-Aged Children with Fragile X Syndrome.

Genes
2022

Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome.

Genes
2022

Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2022

Delineating the CCDC22-related Ritscher-Schinzel syndrome phenotype in the original family.

American journal of medical genetics. Part A
2022

Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease.

Alzheimer's research &amp; therapy
2022

Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome.

Journal of intellectual disability research : JIDR
2022

Phenotypic characteristics and variability in CHARGE syndrome: a PRISMA compliant systematic review and meta-analysis.

Journal of neurodevelopmental disorders
2022

Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.

eLife
2022

Postnatal environmental enrichment enhances memory through distinct neural mechanisms in healthy and trisomic female mice.

Neurobiology of disease
2022

Expanding the phenotype of TAB2 variants and literature review.

American journal of medical genetics. Part A
2022

Detecting sleep apnea in adults with Down syndrome using WatchPAT: A feasibility study.

Research in developmental disabilities
2022

A Novel POGZ Variant in a Patient with Intellectual Disability and Obesity.

The application of clinical genetics
2022

Koolen-de Vries syndrome associated with continuous spike-wave in sleep.

Epileptic disorders : international epilepsy journal with videotape
2022

Sleep disturbances and behavior in Smith-Magenis syndrome.

Research in developmental disabilities
2023

Management of chronic musculoskeletal pain in an adult with Down syndrome using a modified pain neuroscience approach: a case report.

Physiotherapy theory and practice
2022

The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.

Brain : a journal of neurology
2022

Different epilepsy course of a novel AHDC1 mutation in a female monozygotic twin pair.

Seizure
2022

First reported cases with Xia-Gibbs syndrome from India harboring novel variants in AHDC1.

American journal of medical genetics. Part A
2022

HIDEA syndrome: A rare cause of congenital hypoventilation in a premature infant.

Pediatric pulmonology
2022

A novel, de novo intronic variant in POGZ causes White-Sutton syndrome.

American journal of medical genetics. Part A
2022

The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience.

European journal of human genetics : EJHG
2022

The behavioural phenotype of SATB2-associated syndrome: a within-group and cross-syndrome analysis.

Journal of neurodevelopmental disorders
2022

Phenotypic Variability in Phelan-McDermid Syndrome and Its Putative Link to Environmental Factors.

Genes
2022

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group.

Journal of neurodevelopmental disorders
2022

Daytime sleepiness and emotional and behavioral disturbances in Prader-Willi syndrome.

European journal of pediatrics
2022

Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep.

Autism research : official journal of the International Society for Autism Research
2022

Cognitive, Behavioral, and Sensory Profile of Pallister-Killian Syndrome: A Prospective Study of 22 Individuals.

Genes
2022

Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Genes
2022

The presentation, course and outcome of COVID-19 infection in people with Prader-Willi syndrome: unexpected findings from an international survey.

Orphanet journal of rare diseases
2022

Modifiable child and caregiver factors that influence community participation among children with Down syndrome.

Disability and rehabilitation
2022

Children with neurodevelopmental disorders: how do they sleep?

Current opinion in psychiatry
2022

The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.

Journal of neurodevelopmental disorders
2022

CDK13-related disorder: Report of a series of 18 previously unpublished individuals and description of an epigenetic signature.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort.

American journal of medical genetics. Part A
2022

Sleep and daytime behavior in individuals with Christianson Syndrome.

Sleep medicine
2021

[Sleep disturbance associated with Smith-Magenis syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Report of two children with global developmental delay in association with de novo TLK2 variant and literature review.

American journal of medical genetics. Part A
2022

QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality.

Heart rhythm
2021

Epilepsy features in ARID1B-related Coffin-Siris syndrome.

Epileptic disorders : international epilepsy journal with videotape
2021

The spectrum of epilepsy in children with 15q13.3 microdeletion syndrome.

Seizure
2021

Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2022

Heterozygous variants in ZBTB7A cause a neurodevelopmental disorder associated with symptomatic overgrowth of pharyngeal lymphoid tissue, macrocephaly, and elevated fetal hemoglobin.

American journal of medical genetics. Part A
2021

Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.

Orphanet journal of rare diseases
2021

Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome.

Neurobiology of disease
2022

Sanjad Sakati syndrome and sleep-disordered breathing: an undisclosed association.

Sleep &amp; breathing = Schlaf &amp; Atmung
2021

An Extremely Rare Case of Birk-Barel Syndrome With Severe Central Apneas.

Cureus
2022

Airwave oscillometry to measure lung function in children with Down syndrome.

Pediatric research
2021

The Neurological Manifestations of Phelan-McDermid Syndrome.

Pediatric neurology
2022

O'Donnell-Luria-Rodan syndrome: description of a second multinational cohort and refinement of the phenotypic spectrum.

Journal of medical genetics
2021

Phenotypic heterogeneity and mosaicism in Xia-Gibbs syndrome: Five Danish patients with novel variants in AHDC1.

European journal of medical genetics
2021

Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.

JAMA neurology
2021

Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient.

Frontiers in endocrinology
2021

Genotype-Phenotype Correlations in Angelman Syndrome.

Genes
2021

Neurological Phenotype of Mowat-Wilson Syndrome.

Genes
2021

Focusing on Autism Spectrum Disorder in Xia-Gibbs Syndrome: Description of a Female with High Functioning Autism and Literature Review.

Children (Basel, Switzerland)
2021

Posteromedial Hypothalamic Deep Brain Stimulation for Refractory Aggressiveness in a Patient With Weaver Syndrome: Clinical, Technical Report and Operative Video.

Operative neurosurgery (Hagerstown, Md.)
2021

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.

Journal of Alzheimer's disease : JAD
2021

Hyperactive behaviour in Angelman syndrome: the association with sleep problems and age of epilepsy onset.

Journal of intellectual disability research : JIDR
2021

Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder.

Neurology. Genetics
2021

Sleep-disordered breathing and its management in children with rare skeletal dysplasias.

American journal of medical genetics. Part A
2021

Characterization of sleep habits of children with Sotos syndrome.

American journal of medical genetics. Part A
2021

Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities.

Genetics in medicine : official journal of the American College of Medical Genetics
2021

Smith-Magenis syndrome: Report of morphological and new functional cardiac findings with review of the literature.

American journal of medical genetics. Part A
2021

Electro-clinical features in epileptic children with chromosome 15q duplication syndrome.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2021

A de novo frameshift variant of ANKRD11 (c.1366_1367dup) in a Chinese patient with KBG syndrome.

BMC medical genomics
2021

Coexistence of severe developmental delay, epilepsy, and hemangioma in Snijders Blok-Fisher syndrome suggests the presence of a POU3F3-related SNIBFIS endophenotype: A case report.

American journal of medical genetics. Part A
2021

Sleep disorders in rare genetic syndromes: a meta-analysis of prevalence and profile.

Molecular autism
2021

Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.

Molecular autism
2020

Xia-Gibbs Syndrome: A Review of Literature.

Cureus
2020

Diagnosis of Schaaf-Yang syndrome in Korean children with developmental delay and hypotonia.

Medicine
2021

Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.

Clinical genetics
2021

Milder presentation of TELO2-related syndrome in two sisters homozygous for the p.Arg609His pathogenic variant.

European journal of medical genetics
2021

Clinical aspects of a large group of adults with Angelman syndrome.

American journal of medical genetics. Part A
2020

Frequent epileptic apnoea in a patient with Pitt-Hopkins syndrome.

Epileptic disorders : international epilepsy journal with videotape
2020

The adult phenotype of Schaaf-Yang syndrome.

Orphanet journal of rare diseases
2020

Neurological phenotype of Potocki-Lupski syndrome.

American journal of medical genetics. Part A
2020

Xia-Gibbs Syndrome: A Rare Case Report of a Male Child and Insight into Physiotherapy Management.

Cureus
2021

Composite Sleep Problems Observed Across Smith-Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt-Hopkins Syndrome, and ASD.

Journal of autism and developmental disorders
2020

De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.

American journal of human genetics
2020

Behavior and cognitive functioning in Witteveen-Kolk syndrome.

American journal of medical genetics. Part A
2020

Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities.

Journal of intellectual disability research : JIDR
2020

A de novo DDX3X Variant Is Associated With Syndromic Intellectual Disability: Case Report and Literature Review.

Frontiers in pediatrics
2020

A de novo BRPF1 variant in a case of Sudden Unexplained Death in Childhood.

European journal of medical genetics
2020

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.

Lancet (London, England)
2020

Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.

CNS drugs
2020

Lessons learned from 40 novel PIGA patients and a review of the literature.

Epilepsia
2020

Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability.

Proceedings of the National Academy of Sciences of the United States of America
2020

A novel patient with White-Sutton syndrome refines the mutational and clinical repertoire of the POGZ-related phenotype and suggests further observations.

American journal of medical genetics. Part A
2020

OSA and Neurocognitive Impairment in Children With Congenital Heart Disease.

Chest
2020

Angelman Syndrome: From Mouse Models to Therapy.

Neuroscience
2020

Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2020

De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth.

Human genetics
2020

Tatton-Brown-Rahman syndrome: Six individuals with novel features.

American journal of medical genetics. Part A
2020

Missense variants in the Arg206 residue of HNRNPH2: Further evidence of causality and expansion of the phenotype.

American journal of medical genetics. Part A
2020

Associated syndromes in patients with Pierre Robin Sequence.

International journal of pediatric otorhinolaryngology
2019

Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities.

Behavioural neurology
2020

Utility of the pictorial Epworth sleepiness scale in the adult down syndrome population.

Sleep medicine
2019

FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory.

eLife
2020

Obstructive Sleep Apnea in School-Aged Children Presented with Nocturnal Enuresis.

Lung
2020

Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).

American journal of medical genetics. Part A
2020

Healthcare recommendations for Joubert syndrome.

American journal of medical genetics. Part A

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial.
    BMJ open· 2026· PMID 41760142mais citado
  2. Sleep-Disordered Breathing in Chung-Jansen Syndrome.
    International journal of molecular sciences· 2026· PMID 41751879mais citado
  3. Towards Characterizing the Developmental and Behavioral Profiles of ODLURO Syndrome: Shared Features With Wiedemann-Steiner Syndrome and Kabuki Syndrome.
    Clinical genetics· 2026· PMID 41137515mais citado
  4. Etiological Diagnosis and Disease Course of Birk-Barel Syndrome in an Adult Woman with a KCNK9 Variant.
    International medical case reports journal· 2026· PMID 41867391mais citado
  5. Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.
    Alzheimer's &amp; dementia : the journal of the Alzheimer's Association· 2026· PMID 41700075mais citado
  6. Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes.
    J Clin Psychiatry· 2026· PMID 41499180recente
  7. Sexual Health and Transition Needs in an Adolescent Girl With Attention-deficit Hyperactivity Disorder and Smith-magenis Syndrome.
    J Dev Behav Pediatr· 2025· PMID 41396259recente
  8. Respiratory Involvement in HIST1H1E-Related Rahman Syndrome: A Case of Severe Mixed Apnea.
    Am J Med Genet A· 2026· PMID 41358577recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:412069(Orphanet)
  2. OMIM OMIM:615829(OMIM)
  3. MONDO:0014358(MONDO)
  4. GARD:13409(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q25111656(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-apneia do sono obstrutiva-dismorfia ligeira AHDC1-relacionada

ORPHA:412069 · MONDO:0014358
Prevalência
<1 / 1 000 000
Casos
4 casos conhecidos
Herança
Autosomal dominant
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4014419
Wikidata
Wikipedia
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades